InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Hallett David. Director active across 1 company, notably Recursion Pharmaceuticals, INC.. Cumulatively, 2 disclosures have been recorded. History available since 6 February 2026. The latest transaction was disclosed on 17 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations